Cisplatin-based combination chemotherapy in elderly patients with metastatic urothelial cancer

被引：0
|
作者：
Bamias, Aristotelis
Krege, Susanne
Lin, Chia-Chi
Hahn, Noah M.
Ecke, Thorsten
Moshier, Erin L.
Sonpavde, Guru
Godbold, James H.
Oh, William K.
Koutras, Angelos
Pu, Yeong-Shiau
Galsky, Matt D.
机构：
[1] HECOG, Athens, Greece
[2] Univ Athens, Athens, Greece
[3] Alexianer Krefeld GmbH, Urol Klin, Krefeld, Germany
[4] Natl Taiwan Univ Hosp, Taipei, Taiwan
[5] Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46204 USA
[6] HELIOS Hosp, Bad Saarow Pieskow, Germany
[7] Mt Sinai Sch Med, Tisch Canc Inst, Div Hematol & Med Oncol, New York, NY USA
[8] US Oncol Res LLC, McKesson Specialty Hlth, The Woodlands, TX USA
[9] Deke Slayton Canc Ctr, Webster, TX USA
[10] Mt Sinai Med Ctr, New York, NY 10029 USA
[11] Hellen Cooperat Oncol Grp Data Off, Athens, Greece
[12] Natl Taiwan Univ, Taipei 10764, Taiwan
[13] Mt Sinai Med Ctr, Tisch Canc Inst, New York, NY 10029 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 06期
关键词：
D O I：
10.1200/jco.2013.31.6_suppl.269
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
269
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    M B Polee
    W C J Hop
    T C Kok
    F A L M Eskens
    M E L van der Burg
    T A W Splinter
    P D Siersema
    H W Tilanus
    G Stoter
    A van der Gaast
    British Journal of Cancer, 2003, 89 : 2045 - 2050
  • [42] Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy
    Polee, MB
    Hop, WCJ
    Kok, TC
    Eskens, FALM
    van der Burg, MEL
    Splinter, TAW
    Siersema, PD
    Tillanus, HW
    Stoter, G
    van der Gaast, A
    BRITISH JOURNAL OF CANCER, 2003, 89 (11) : 2045 - 2050
  • [43] Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer
    Fukui, I
    Yonese, J
    Tsukamoto, T
    Yoshida, T
    Kim, T
    Tohma, T
    Ishiwata, D
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2001, 48 (01) : 88 - 93
  • [44] Combination chemotherapy with ifosfamide, 5-fluorouracil, etoposide and cisplatin for metastatic urothelial cancer
    Iwao Fukui
    Junji Yonese
    Tetsuro Tsukamoto
    Tetsuya Yoshida
    Taisei Kim
    Tsuguhiro Tohma
    Daisuke Ishiwata
    Cancer Chemotherapy and Pharmacology, 2001, 48 : 88 - 93
  • [45] Cost-effectiveness of Pembrolizumab for Patients with Advanced, Unresectable, or Metastatic Urothelial Cancer Ineligible for Cisplatin-based Therapy
    Patterson, Karl
    Prabhu, Vimalanand
    Xu, Ruifeng
    Li, Haojie
    Meng, Yang
    Zarabi, Natalie
    Zhong, Yichen
    Batteson, Rachael
    Pellissier, James
    Keefe, Stephen
    Grivas, Petros
    de Wit, Ronald
    EUROPEAN UROLOGY ONCOLOGY, 2019, 2 (05): : 565 - 571
  • [46] Advanced ovarian cancer in elderly: results of consecutive trials with Cisplatin-based chemotherapy
    Chiara, S
    Vincenti, M
    Lionetto, R
    Pastorino, S
    Bruzzone, M
    Gadducci, A
    Carnino, F
    Rosso, R
    Conte, PF
    ANNALS OF ONCOLOGY, 1998, 9 : 62 - 62
  • [47] Advanced ovarian cancer in the elderly: results of consecutive trials with cisplatin-based chemotherapy
    Chiara, S
    Lionetto, R
    Vincenti, M
    Bruzzone, M
    Nobile, MT
    Gadducci, A
    Carnino, F
    Rosso, R
    Conte, P
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2001, 37 (01) : 27 - 34
  • [48] Prognostic factors influencing the outcome of cisplatin-based chemotherapy in patients with recurrent or metastatic cancer of the head and neck
    Kawecki, Andrzej
    Jagielska, Beata
    Rolski, Wojciech
    Symonides, Malgorzata
    ANNALS OF ONCOLOGY, 2004, 15 : 144 - 144
  • [49] The comparison of oncologic outcomes between metastatic upper tract urothelial carcinoma and urothelial carcinoma of the bladder after cisplatin-based chemotherapy
    Hsieh, Meng-Che
    Chiang, Po-Hui
    Rau, Kun-Ming
    Chen, Yen-Yang
    Su, Yu-Li
    Huang, Cheng-Hua
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (11) : 495.e9 - 495.e14
  • [50] Prospective evaluation of the feasibility of cisplatin-based chemotherapy for elderly lung cancer patients with normal organ functions
    Oshita, F
    Kurata, T
    Kasai, T
    Fukuda, M
    Yamamoto, N
    Ohe, Y
    Tamura, T
    Eguchi, K
    Shinkai, T
    Saijo, N
    JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (12): : 1198 - 1202
12345